Mfn Partners Management, LP Takeda Pharmaceutical CO LTD Call Options Transaction History
Mfn Partners Management, LP
- $3.18 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TAK
# of Institutions
341Shares Held
76MCall Options Held
1.85MPut Options Held
121K-
Capital Research Global Investors Los Angeles, CA13.1MShares$170 Million0.04% of portfolio
-
Mondrian Investment Partners LTD London, X012.1MShares$156 Million2.47% of portfolio
-
Morgan Stanley New York, NY5MShares$64.6 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.21MShares$54.5 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.12MShares$40.3 Million0.07% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $40.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...